Compound ID | 973
CX1 (para-guanidinoethylcalix[4]arene)
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Demonstrates gram positive and negative activity including multi-drug resistant strains |
| Propensity to select resistant mutants: | Through serial passaging with S. aureus no resistance was seen |
| Description: | Grare M, Ribon A, Massimba Dibama H, et al.In vitro mutation studies with a new promising compound, para-guanidinoethylcalix[4]arene. 48-ICAAC-46-IDSA-2008 2008;317 |
| Institute where first reported: | Nancy University, France |
| Year first mentioned: | 2008 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.